A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray d ... more
SynenTec To Take Over Roche Cellavista System
Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal support and development of the technology for its customers.
The Cellavista Imaging System for noninvasively measuring cell expansion uses brightfield and fluorescence detection with multiwell plates, chamber slides or RoboFlasks, for a broad range of cellular applications in cell line development, cellular research and drug discovery.
“It is very important that we ensure uninterrupted support for our customers. We have found the ideal match in SynenTec”, said Dan Zabrowski, Head of Roche Applied Science.
“This acquisition adds significant value for Cellavista customers by enabling them to directly discuss their requirements and needs with the developer of the system,” says Matthias Pirsch, CEO of SynenTec.
Over the last years, SynenTec collaborated with Roche in cell imaging, and was closely involved in the development, service and support of Cellavista Systems. With the business transfer SynenTec will take on worldwide distribution of Cellavista Systems, as well as providing application support and service. Roche will remain the primary contact partner for all support needs for Cellavista Systems delivered by Roche or Innovatis over a transition phase until SynenTec assumes full responsibility on June 01, 2013.
- cell analysis
The xCELLigence RTCA System of Roche is being used in the European Union’s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems”) Project, a joint study funded by the European Cosmetics Association (Colipa) and the European Commission, where Ro ... more
The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The seq ... more
Transfection of cells is one of the main techniques used to influence gene expression. Most primary cells and human skeletal myoblasts (SkMC) in particular are very difficult to transfect, whereas for cell lines such as C2C12, many suitable transfect more
The main focus in proteomic studies is on the identification of proteins in given biological samples. Proteins isolated and separated from a given sample (e.g., whole cell lysates, blood or tissue, protein complexes) by immunoprecipitation or affinit more
One of the most interesting aspects of real-time PCR based on detection of fluorophoric-labeled oligonucleotides, such as Hydrolysis probes, and Molecular Beacons, is the possibility of being able to detect conveniently multiple targets in the same more
- 1Groundbreaking experimental method will speed up protein analysis substantially
- 2State-of-the-art text mining technologies for chemistry
- 3Shimadzu acquires specialist for isotope labeled standards
- 4Tiny nanoparticles offer significant potential in detecting and treating disease
- 5Eurofins expands its footprint in the Balkan region
- 6Eurofins acquires clinical diagnostics company in Italy
- 7More durable, versatile wearable for diabetes monitoring
- 8New sensors could enable more affordable detection of pollution and diseases
- 9Waters Corporation elects Flemming Ornskov to Board of Directors
- 10New femto-camera with quadrillion fractions of a second resolution
- Shimadzu acquires specialist for isotope labeled standards
- Groundbreaking experimental method will speed up protein analysis substantially
- We are much more unique than assumed
- LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
- PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion